Overview

• Advocate Vishal Tiwari filed a PIL seeking transfer of all FIRs to the CBI and a court‑monitored national commission to investigate DEG‑tainted syrups and mandate recalls and testing.
• Madhya Pradesh barred two additional products — ReLife and Respifresh TR — after officials reported DEG above limits and moved to seize stocks while asking Gujarat to examine the manufacturers.
• Punjab and Puducherry announced prohibitions on Coldrif, joining a growing list that includes Tamil Nadu, Kerala, Uttar Pradesh, Rajasthan, Karnataka, Maharashtra, Goa, Himachal Pradesh and others.
• An inspection by Tamil Nadu Drugs Control cited over 350 GMP lapses at Sresan Pharmaceuticals, halted production, ordered market withdrawal and issued a show‑cause notice for full manufacturing records.
• The Centre launched risk‑based inspections of drug units and advised against prescribing cough and cold medicines to children under two, as police probes and a state SIT proceed alongside stock seizures.